RESPIRATORY MEDICINE, vol.109, no.9, pp.1120-1125, 2015 (SCI-Expanded)
Background: In this study, we compared the clinical and immunological efficacy of nebulized corticosteroid (CS) to systemic route during treatment of moderate asthma attack in children.